Greenleaf Trust’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$615K Buy
8,064
+58
+0.7% +$4.18K 0.01% 440
2025
Q4
$511K Buy
8,006
+2,005
+33% +$124K ﹤0.01% 494
2025
Q3
$378K Buy
6,001
+53
+0.9% +$3.7K ﹤0.01% 570
2025
Q2
$444K Sell
5,948
-524
-8% -$41.2K ﹤0.01% 519
2025
Q1
$570K Buy
6,472
+2
+0% +$189 0.01% 465
2024
Q4
$591K Sell
6,470
-175
-3% -$17.9K 0.01% 471
2024
Q3
$744K Buy
6,645
+128
+2% +$12.8K 0.01% 417
2024
Q2
$638K Buy
6,517
+185
+3% +$18.4K 0.01% 415
2024
Q1
$635K Sell
6,332
-143
-2% -$12.6K 0.01% 407
2023
Q4
$582K Buy
6,475
+333
+5% +$26.5K 0.01% 416
2023
Q3
$471K Sell
6,142
-358
-6% -$29.7K 0.01% 454
2023
Q2
$544K Sell
6,500
-476
-7% -$38.7K 0.01% 431
2023
Q1
$588K Buy
6,976
+409
+6% +$35.1K 0.01% 402
2022
Q4
$535K Sell
6,567
-1,318
-17% -$106K 0.01% 427
2022
Q3
$560K Buy
7,885
+793
+11% +$71.3K 0.01% 369
2022
Q2
$637K Buy
7,092
+148
+2% +$15.3K 0.01% 328
2022
Q1
$778K Sell
6,944
-708
-9% -$83K 0.01% 301
2021
Q4
$925K Buy
7,652
+193
+3% +$21.5K 0.01% 264
2021
Q3
$751K Sell
7,459
-126
-2% -$13.9K 0.01% 287
2021
Q2
$886K Buy
7,585
+168
+2% +$20.2K 0.01% 250
2021
Q1
$817K Buy
7,417
+3,758
+103% +$408K 0.01% 248
2020
Q4
$367K Buy
3,659
+362
+11% +$33.6K ﹤0.01% 413
2020
Q3
$258K Buy
3,297
+132
+4% +$9.95K ﹤0.01% 449
2020
Q2
$220K Buy
+3,165
New +$199K ﹤0.01% 484
2019
Q1
Sell
-2,878
Closed -$210K 535
2018
Q4
$210K Buy
+2,878
New +$229K ﹤0.01% 440
2018
Q1
Sell
-345
Closed -$32K 575
2017
Q4
$32K Hold
345
﹤0.01% 527
2017
Q3
$31K Buy
+345
New +$29.4K ﹤0.01% 498

Other funds holding EMN

Greenleaf Trust's EMN Position: Q1 2026 in Review

Greenleaf Trust increased its Eastman Chemical (EMN) stake by 0.72% in Q1 2026, buying an estimated $4.18K and bringing the position to 8,064 shares worth $615K. The position accounts for 0.01% of the portfolio, ranked #440.

Greenleaf Trust first reported a position in EMN in Q3 2017 and has held it in 27 quarters since. The position peaked at $925K in Q4 2021. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Greenleaf Trust held 8,064 shares of Eastman Chemical worth $615K as of Q1 2026.
  • Greenleaf Trust bought 58 Eastman Chemical shares in Q1 2026, an estimated $4.18K.
  • Eastman Chemical made up 0.01% of Greenleaf Trust's portfolio in Q1 2026, its #440 holding.
  • Greenleaf Trust first reported a position in Eastman Chemical in Q3 2017 and has held it in 27 quarters since.
  • Greenleaf Trust's Eastman Chemical position peaked at $925K in Q4 2021.
  • 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Greenleaf Trust's 13F filing for Q1 2026, filed 27 Apr 2026.